M

R

MASETTI , Riccardo

Last name: MASETTI

First name: Riccardo

2022 (v1)

Publication

Metadata-only

Safety and Efficacy of Ribociclib in Combination with Letrozole in Patients with HR+, HER2- Advanced Breast Cancer: Results from the Italian Subpopulation of Phase 3b CompLEEment-1 Study

De Laurentiis, Michelino Caputo, Roberta Mazza, Manuelita

Ribociclib plus letrozole demonstrated manageable safety and efficacy profiles in hormone receptor-positive (HR+), human epidermal growth factor receptor-2-negative (HER2-) advanced breast cancer (ABC) in the Phase 3b CompLEEment-1 trial.

Uploaded on: February 14, 2024
2017 (v1)

Publication

Metadata-only

Outcome of children with acute leukemia given HLA-haploidentical HSCT after αβ T-cell and B-cell depletion

Locatelli, Franco Merli, Pietro Pagliara, Daria

Allogeneic hematopoietic stem cell transplantation (HSCT) from an HLA-haploidentical relative (haplo-HSCT) is a suitable option for children with acute leukemia (AL) either relapsed or at high-risk of treatment failure. We developed a novel method of graft manipulation based on negative depletion of αβ T and B cells and conducted a prospective...

Uploaded on: April 14, 2023